Form 4 for GUTS FRACTYL HEALTH, INC.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0000950170-24-012836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-02-08 | 2024-02-06 | GUTS | Caplan Jay David | Pres, Chief Product Off | C - Cnv Deriv | — | +142.1K | 358.8K | +66% | — |
| DMI | 2024-02-08 | 2024-02-06 | GUTS | Caplan Jay David | Pres, Chief Product Off | C - Cnv Deriv | — | -305.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | C | A | 118,810 | — | 118,810 | I By Family Trust | — | — | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |
| 2 | Common | Common Stock | 2024-02-06 | C | A | 23,299 | — | 358,806 | I By Trust | — | — | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. (F2) The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust. |
| 3 | Derivative | Series A Preferred Stock | 2024-02-06 | C | D | 50,000 | — | 0 | I By Trust | — · — to — | 23,299 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |
| 4 | Derivative | Series B Preferred Stock | 2024-02-06 | C | D | 177,726 | — | 0 | I By Family Trust | — · — to — | 82,817 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |
| 5 | Derivative | Series C-1 Preferred Stock | 2024-02-06 | C | D | 44,730 | — | 0 | I By Family Trust | — · — to — | 20,843 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |
| 6 | Derivative | Series C-2 Preferred Stock | 2024-02-06 | C | D | 32,514 | — | 0 | I By Family Trust | — · — to — | 15,150 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |